Bone Biologics (BBLG) Return on Capital Employed (2016 - 2017)
Bone Biologics (BBLG) has disclosed Return on Capital Employed for 2 consecutive years, with 2.75% as the latest value for Q3 2017.
Bone Biologics (BBLG) has disclosed Return on Capital Employed for 2 consecutive years, with 2.75% as the latest value for Q3 2017.